Study objective -To ascertain, from the published reports to date, whether or not a significantly increased risk ofbreast cancer is specifically attributable to a history of induced abortion, independent of spontaneous abortion and age at first full term pregnancy (or first live birth); to establish the relative magnitude of such risk increase as may be found, and to ascertain and quantify such risk increases as may pertain to particular subpopulations of women exposed to induced abortion; in particular, nulliparous women and parous women exposed before compared with after the first full term pregnancy. Included studies -The meta-analysis includes all 28 published reports which include specific data on induced abortion and breast cancer incidence. Since some study data are presented in more than one report, the 28 reports were determined to constitute 23 independent studies. Overall induced abortion odds ratios and odds ratios for the different subpopulations were calculated using an average weighted according to the inverse of the variance. An overall unweighted average was also computed for comparison. No quality criteria were imposed, but a narrative review of all included studies is presented for the reader's use in assessing the quality of individual studies. Excluded studies -All 33 published reports including data on abortion and breast cancer incidence but either pertaining only to spontaneous abortion or to abortion without specification as to whether it was induced or spontaneous. These studies are listed for the reader's information. Results -The overall odds ratio (for any induced abortion exposure; n = 21 studies) was 1.3 (95% confidence interval of 1.2, 1.4). For comparison, the unweighted overall odds ratio was 1.4 (1.3,1.6). The odds ratio for nulliparous women was 1.3 (1.0,1.6), that for abortion before the first term pregnancy in parous women was 1.5 (1.2,1.8), and that for abortion after the first term pregnancy was 1.3 (1.1,1.5).
after the first full term pregnancy. Included studies -The meta-analysis includes all 28 published reports which include specific data on induced abortion and breast cancer incidence. Since some study data are presented in more than one report, the 28 reports were determined to constitute 23 independent studies. Overall induced abortion odds ratios and odds ratios for the different subpopulations were calculated using an average weighted according to the inverse of the variance. An overall unweighted average was also computed for comparison. No quality criteria were imposed, but a narrative review of all included studies is presented for the reader's use in assessing the quality of individual studies. Excluded studies -All 33 published reports including data on abortion and breast cancer incidence but either pertaining only to spontaneous abortion or to abortion without specification as to whether it was induced or spontaneous. These studies are listed for the reader's information. Results -The overall odds ratio (for any induced abortion exposure; n = 21 studies) was 1.3 (95% confidence interval of 1.2, 1.4). For comparison, the unweighted overall odds ratio was 1.4 (1.3,1.6). The odds ratio for nulliparous women was 1.3 (1.0, 1.6) , that for abortion before the first term pregnancy in parous women was 1.5 (1.2,1.8), and that for abortion after the first term pregnancy was 1.3 (1.1,1.5).
Conclusions -The results support the inclusion of induced abortion among significant independent risk factors for breast cancer, regardless of parity or timing of abortion relative to the first term pregnancy. Although the increase in risk was relatively low, the high incidence of both breast cancer and induced abortion suggest a substantial impact of thousands of excess cases per year currendy, and a potentially much greater impact in the next century, as the first cohort of women exposed to legal induced abortion continues to age.
(J Epidemiol Community Health 1996;50:481-496)
Epidemiological evidence of a positive association between induced abortion and the incidence of breast cancer was first presented by Segi et al' in 1957 based on cases diagnosed between 1948 and 1952. Experimental evidence of a causal association between induced abortion and breast cancer in rodents was presented by Russo and Russo2 in 1980 . Yet, despite the alarmingly high incidence of both breast cancer and induced abortion, the last four decades have produced neither consensus of opinion within the medical research community nor a sense of urgency to arrive at one. Although a few dozen studies have appeared worldwide, and many of them support a positive association, the potential of induced abortion as a breast cancer risk factor continues largely to be minimised. For example, the recent study by Daling et al' which reported a significant, 50% increase in the overall risk attributable to induced abortion, was published in the Journal of the National Cancer Institute with an accompanying editorial by Rosenberg4 which described the results as "far from conclusive". Similarly, in a more recent study of women in Greece, Lipworth et al' confirmed the overall findings of Daling et al' but nevertheless concluded: "At this stage, perhaps all that can be definitively stated is that any risk associated with induced abortion is at most statistically marginal". Previous reviews have also not served to clarify this issue. The New England J7ournal of Medicine's extensive, 1992 review of breast cancer 6 fails to mention abortion at all, even among potential risk factors. The same is true for the recent breast cancer review 7 published in The Lancet. Reviewers who have included a discussion of induced abortion as a real or potential risk factor have not been comprehensive, [8] [9] [10] [11] [12] and also often fail (as do many ofthe original epidemiological studies) to distinguish between induced and spontaneous abortion.89 Even when the distinction is made, erroneous citations are common. For example, . The analysis is also restricted to abortion before first full term pregnancy. Cases were age matched both to healthy "neighborhood" and "friend" controls, and, although RR calculations are presented for spontaneous and induced abortion combined, raw data are given, so that the crude OR may be calculated specifically for induced abortion. In calculating the crude OR, we opted to compare exposed subjects with those who simply had no exposure to induced abortion, rather than with those who had no abortion ofeither type, thus generating a more conservative point estimate (2.37 versus 2.50). A subsequent study of this population with additional patients and controls," did not differentiate between induced and spontaneous abortion.
The 1982 study of Nishiyama"6 compared 767 radical mastectomy patients from a single prefecture in Japan with an equal number ofage matched, normal controls identified through a mass breast cancer screening programme. The median age of patients and controls was approximately 51 years. 1336 control women drawn at random from the general population and stratified by age in decades. The only data given which specifically related to induced abortion were for nulliparous women. Although this RR was reported as 3.85 and significant, since the reference group consisted entirely of parous women, this figure represents the combined effect of nulliparity and induced abortion. Fortunately, the authors also calculated the RR of nulligravid women, compared with parous women. Thus, we were at least able to calculate a corrected RR of 2.91 for nulliparous women (table 2) .
The 1988 study of Rosenberg et ar6 is a continuation of the 1983 study of Helmrich et al,39 which did not separate induced and spontaneous abortion data. Although this study includes data from four major east coast cities and includes 3200 cases and 4844 cancer free hospital controls under 70 years of age, it is severely weakened by a very large age difference and a consequent cohort difference in induced abortion exposure rates between cases and controls. In particular, since the subjects were collected between 1978 and 1985, and since the median patient age was 52 and the median control age 40 years, the average patient in the study was in her 40's, but the average control subject was only about 30 when induced abortion was legalised nationwide in 1973. In fact, more than three times the number of controls (49%) as patients (16%) in the study were under age 40. Nevertheless, an overall RR of 1.2 (with borderline significance) emerges when the data for all ages and parities are combined (table 2) .
The 1989 study of Howe et aF7 reports data on all 1451 women from upstate New York (including Long Island) under the age of 40 who were diagnosed with breast cancer between 1976 and 1980. Since this age matched, neighborhood control study was based entirely on computerised records, the possibility of recall bias was eliminated, although the possible effects of certain variables such as family history could not be evaluated. Unfortunately, data presented on abortion before first full term pregnancy did not distinguish between induced and spontaneous abortion. A particularly noteworthy finding ofthis study is of 10 patients and no controls with a history of two consecutive induced abortions.
The 1989 study of Harris et a158 is a computerised registry study of the cohort of Swedish women who had induced abortions during the period 1966-74. Although the prospective nature of the study precludes the existence of response bias, the study nonetheless suffers from serious methodological weaknesses. Firstly, the incidence of breast cancer among subjects who had undergone induced abortion was compared with the expected incidence from general population statistics. These statistics included the study cohort and were not adjusted for the protective effect of parity, even though the nulliparity rate was considerably higher among the general population (49%) than the study cohort (41%). Secondly, the authors inexplicably restricted their study cohort to those whose abortion occurred before age 30. This had the effect ofdisproportionately eliminating older breast cancer patients from the analysis, as the authors' own comparison of "total cohort" versus "study cohort" data shows. However, a case-control study with overlapping authorship and most of the study population in common was published by Adami et ar9 in 1990. This latter study includes 317 Swedish patients (with one age matched, nonhospital control each) and 105 Norwegian cases (with two age matched controls each) under the age of 45 and 40 years, respectively, and diagnosed during 1984-85. As noted above, the Swedish population is largely included in the computerised cohort study of Harris et al,58 but we have chosen the better designed, casecontrol study59 for inclusion in the overall OR calculation of the meta-analysis to represent this population (category 1, table 2), although the point estimates do not differ substantially between the two studies (0.77 versus 0.9, respectively). Concerning data pertaining to abortion before first full term pregnancy, Harris et al58 reported data for women who were nulliparous versus parous at the time of abortion, who are thus included in the meta-analysis under category nos 2 and 3 (table 2). However, the OR for abortion before first full term pregnancy among women parous at diagnosis is only given in the study of Adami et al. 59 Unfortunately, the OR for this statistic given in the paper (0.6; 95% CI: 0.3,1.5) does not include multiple abortions, for which the authors did not calculate an OR. We have therefore recalculated the OR for one or more abortions using the raw data given. The value thus obtained (0.82; 95% CI: 0.44,1.51) is included in the meta-analysis under category 2b (table 2) .
A continuing case-control study in the greater Milan area of northern Italy has generated a number of published reports, four of which60-63 have included data specifically on induced abortion. The most recent, a 1993 report by La Vecchia et al3 is a summary of data on many types of cancer, including 3048 breast cancer cases and 4981 cancer free, hospital controls. In this report, the data on breast cancer are limited to overall risk among subjects with one or two or more induced abortions, which we have combined for category 1 in the meta-analysis (table 2) . Data from the 1987,60 1991,61 and 199262 reports, are superseded by those of the 1993 paper.63 The 1991 paper by Parazzini et alV also reports RRs for abortion before first birth, but only distinguishes between induced and spontaneous abortion in nulliparous women (440 cases and 449 controls). Hence, data from this report are included in the meta-analysis under category 2a (table  2 ). An unusual feature of this study population is the lack of a significant overall trend in risk with respect to parity, with subjects with 1-3 children showing raised (1.2-1.4, but not statistically significant) risks, and those with four or more children, slightly (0.8) but significantly reduced risk.
The 1993 study of Moseson et al64 on 370 breast cancer patients and 783 normal controls from a New York City screening clinic is un-usual in several important respects. Firstly, the study was published many years after its completion, with patients diagnosed in the half decade of 1977-81. Since most cases and controls were postmenopausal, very few would have been exposed to induced abortion, which had only been legalised in New York in 1970. Secondly, this cohort effect is compounded by substantial differences in age between cases and controls. The authors acknowledged that cases were an average of 3 years older than controls; thus more of them were postmenopausal. More importantly, almost twice as many controls as patients (16.1% versus 8.9%, respectively) were in the 22-44 year age stratum, the only age stratum that would have had any significant exposure to legally induced abortion. Hence, despite adjustment of the OR for age in the analysis, considerable underestimation of the overall RR for induced abortion might be expected. This difficulty appears to have been avoidable, since the The 1994 study of Andrieu et al/7 focused on the interaction of abortion and family history. The study population is comprised of 495 cases, 354 "friend or colleague" controls, and 431 non-cancer hospital controls, all obtained between 1983 and 1987 from a study on oral contraceptive use and breast cancer. The age range of subjects was 20-56 years, with a mean of approximately 44.5 years for patients and both control groups, even though they had been only matched to + 5 years. Of particular note is the interaction of induced abortion and family history of breast cancer (mother, sister, grandmother, or aunt). Among subjects reporting a positive family history and one induced abortion, an OR of 1.3 (non-significant) was calculated, which rose to a significant 7.1 among subjects reporting two or more induced abortions.
The 1994 studies of White et al'8 and Daling et al' concern essentially the same white patient population derived from a tumour registry in Washington state -patients aged 45 and under who were diagnosed between 1983 and 1990. Controls were identified from the general population through random digit telephone dialing, and appear to be about 2 years younger than the patients, on average. The only difference in the patient population of the two studies is that the former (n=747) was restricted to invasive cancer, while the latter (n=845) also included 98 patients with in situ carcinoma. Both studies used the same control group.
The former studyy6' was designed primarily to investigate the effects of oral contraceptive use on breast cancer risk, while the latter3 focused on induced abortion. However, due to differences in study design, we have elected to include some of the data from each study in the meta-analysis, for the following reasons. White et The 1995 study of Brinton et al'9 is focused on the effect of oral contraceptives on breast cancer risk, and shows only data for one and two or more induced abortions in women who were ever pregnant. The 1648 patients (with invasive or in situ carcinoma) and 1505 controls were drawn from three regions of the US: Atlanta, Georgia, central New Jersey, and the same Seattle, Washington area covered earlier by the studies of White et al68 and Daling et al3, with subject collection in the Seattle area beginning when that of the previous studies left off -ie, mid-1990, and ending with the end of 1992. Patients in the Brinton et al study69 also appear to be slightly older than controls. An unusual feature of this study is the adjustment for race (white, African-American, or "other"), rather than keeping the study uniracial or matching for race. The authors' calculation indicating an OR of 1.20 for AfricanAmerican women is not surprising, since it is known that breast cancer incidence is higher in premenopausal African-American women than in white American women. However, it is a cause for concern that ORs for other variables, such as induced abortion, are adjusted for this difference, since the reason for the racial difference is unknown, and since AfricanAmerican women are vastly over represented among induced abortion patients. Thus it is possible that adjustment for race, rather than eliminating the effect of a confounding variable, actually nullifies the effect of the variable under study. Another question is raised by the fact that all information on control subjects was truncated at the time of initial screener interview, but the authors do not indicate that the period during which the controls were screened for participation is the same as the period during which patients in the study were diagnosed. If these periods did not overlap precisely, any differences would constitute an additional source of error. It is expected that Brinton and colleagues will publish a sequel to this study focussing on induced abortion, at which time the results may be more fully evaluated.
The 1995 study of Greek women by Lipworth et ar involved 820 patients, (diagnosed during the years 1989 through 1991), 795 cancer free hospital controls, and 753 "healthy visitor" controls. Although controls were matched for age and residence, the age matching was crude (± 5 years), and age distribution data were not given. Hence significant age discrepancies between cases and controls may exist.
The 1995 study by Rookus Of particular concern is the exclusion of 66 cases and 50 controls for whom the precise timing of pregnancy termination was not known with respect to the six month dividing line. Since 66 cases represent, proportionately, twice as many subjects as 50 controls, a significantly (twofold) raised risk among these women is thus ignored. Although these authors also reported having found no statistically significant differences regarding timing of abortions relative to full term pregnancies (categories 2 and 3) or number of abortions, no data for these subgroups are given. Finally, this study evidences a trend, similar to that found by Laing et al5 of increasing risk with age at diagnosis (divided into five 10 year age strata). Thus, the reported RR of 1.11 for women under 40 years of age at diagnosis rises to 2.02 for women age 70 and over.
STATISTICAL METHODS
Descriptive statistics were presented as ORs or RRs in all studies included in this review, except in the case of Segi et al,' from which ORs were calculated as described previously. Except for five studies which reported only raw ORs,'5 16 18 52 57 a multiple logistic regression analysis was used to arrive at an estimate of the OR, adjusted for age and other prognostic factors such as parity and age at first full term pregnancy (or age at first live birth). In addition, one of the studies reporting only raw ORs also stated that the use of the conditional binomial distribution did not change the ORs.57 Seven of the studies in the meta-analysis did not report an overall dichotomous OR (category 1), but rather, reported separate ORs on the basis of single versus multiple exposures,'654 68 69 differences in age at diagnosis,65 or differences in parity.5356 For these studies, the overall dichotomous OR and 95% CI were calculated for each study according to a weighted average formula using the natural logarithm ofthe given For the meta-analysis, a weighted average for the pooled OR was obtained for each exposure category using the log OR and inverse of the variance as described above. For overall, dichotomous exposure (category 1), the unweighted average was also calculated for comparison ( figure 1 ).
Results Figure 1 shows a semi-logarithmic plot of the overall dichotomous ORs and 95% CIs (error bars) for induced abortion and breast cancer (category 1) for each of the 21 independent studies for which such data were presented (representing data published in 26 separate reports) or could be calculated (see Statistical methods). The weighted (1.3, 1.2-1.4) and unweighted (1.4, 1.3-1.6) averages, both of which significantly exceed unity, are also shown. Table 2 lists the ORs and CIs for each of the 23 independent studies (representing data published in 28 separate reports) included in the meta-analysis for each category for which data were reported. Table 3 summarises the weighted averages and 95% CIs for each category. All of the averages significantly exceed unity. -we have chosen to include both as separate studies. However, it is noteworthy that the overall ORs of these two studies were similar (1.2 and 1.0, respectively), and the possible error (in the direction of underestimation of the overall OR) due to the partial overlap would necessarily be slight. Regarding differences in study quality, we have chosen the most widely accepted and objective method of weighting, namely, according to the inverse ofthe reported variance of the log OR. For comparison, we have also calculated the unweighted average of the overall OR, and, although its CI is (not surprisingly) somewhat wider, the point estimate (1.4) is very close to the weighted average (1.3), and both are significant. Acknowledging, however, that no statistical formula could possibly account for the many large and small differences in study design and descriptive statistical presentation in the various reports, we also have opted to include a rather detailed narrative review of the individual included studies as well as the individual data entered into the quantitative meta-analysis. By this method, we have aimed to provide the reader with as complete as possible a qualitative as well as quantitative review of the extant literature. Ideally, a meta-analysis would be based on a compilation of the raw data (including data on other prognostic variables) from each subject from each component study. A logistic regression analysis could then be applied to the master data base to get a more reliable estimate of the overall OR. With such a database it might even be possible to perform more sophisticated statistical analyses than logistic regression, such as proportional hazards regression of the age at time of breast cancer diagnosis.
Another general limitation to the present meta-analysis is the observational nature of studies on abortion and breast cancer, since observational studies inherently contain more bias than randomised trials. Recent discussions in the literature7"77 have addressed the concerns that arise with claims of causality when relatively small ORs are reported, whether in a single study or in a set of studies. Given the relatively small magnitude of the cumulative ORs (table 3) we have calculated, the question arises as to whether these are real effects or artifacts of the biases that occur within observational studies. One attempt to distinguish artifact from reality is to look for consistency across the independent studies. Table 4 illustrates the clear consistency that emerges in the present meta-analysis, with the overwhelming majority of the studies favouring a positive association.
THE "FILE DRAWER" PROBLEM
In any meta-analysis, the "file drawer" argument may be invoked, particularly if the magnitude of both the individual and cumulative ORs (tables 2 and 3) is small. That is to say, if there is an underlying bias against the publication of negative data, the significantly elevated ORs generated by the present metaanalysis may be artefactual. However, since induced abortion is an unusual surgical procedure which is politically and legally, as well as personally, sensitive, there is indirect evidence to suggest the opposite trend in bias, that is, against the publication of data which reflect a positive association with breast cancer incidence.
It is certainly understandable that the first observation of increased breast cancer risk with induced abortion should have been interpreted with caution. For example, Segi et all back in 1957, having observed that, "The rate of artificial interruption of pregnancy is significantly larger in all the subgroups among the cancer cases than the control cases", were nonetheless "rather hesitant . . . in inducing some definite conclusions". However, it is peculiar that almost 40 years and over 20, mostly positive studies later, the most recent investigators should report their own, significantly positive data with extraordinary reluctance. Witness the literal bottom line of the recent report of Newcomb et al": "our data suggest that the risk of breast cancer associated with any pregnancy termination is likely to be small, if it exists at all".
Perhaps the most widely known study which reported a positive association between induced abortion and breast cancer is that of Pike et at" in 1981, on young women in California.
The following year, Vessey et al,'4 in their own study at Oxford, called the findings of Pike et al "provocative and worrying" and offered their own (slightly and insignificantly negative results) as "entirely reassuring", even though their study population contained "only a handful" of subjects with induced abortion, and was therefore inadequate to address the issue of induced abortion and breast cancer risk at all. Finally, the conspicuous absence of any mention of induced abortion relative to breast cancer risk in prominent medical journal reviews (eg, the New England Jrournal of Medicine6 and Lancet7) may be seen against the conspicuous claim, by the American Medical Association in its own Journal,78 as recently as December of 1992, that the risk of maternal death from childbirth is, at "a conservative estimate" (of 4.7 deaths per 100 000 live births) "nearly 12 times greater than the legal abortion mortality ratio of 0.4". Lifetime breast cancer risk is currently estimated to be approximately 12% in the US, for example, where induced abortion is a very common exposure (approximately 1.6 million per year). Thus, it is easily seen that any demonstrable risk increase due to induced abortion would make this elective procedure far more risky than live birth, at least in the long term, as the risk of immediate maternal death is vanishingly small for any pregnancy outcome. Therefore, while we are aware of no specific cases wherein positive data have been withheld from publication, indirect evidence suggests that any bias against publication of data concerning induced abortion and breast cancer would be in the direction of keeping positive rather than negative data "in the file drawer".
RECALL OR RESPONSE BIAS
The possibility of bias due to differential recall and/or reporting by patients versus control subjects merits serious consideration in any retrospective questionnaire or interview based study. It 79 In this study, the authors compared prospective, computerised data reported in their 1989 study58 with data on the same Swedish study population that had been gathered by retrospective interview for an earlier (1986)80 study on oral contraceptives and breast cancer. As evidence of response bias, the authors reported a differential discordance between computer registry based data and interview based data, specifically, that an excess of cases relative to controls (7 versus 1, respectively) had "over reported" induced abortions, and that an excess of controls relative to cases (16 versus 5, respectively) had "under reported" induced abortions.79 From these discrepancies, the authors calculated that the OR for induced abortion based on the interview data (0.95) was significantly inflated compared with that based on the computer registry data (0.63; ratio of the ORs= 1.5, 95% CI 1.1,2.1).79
With regard to the issue of "over reporting" in this study,79 we do not hesitate to concur with Daling et al,3, who commented, "we believe it is reasonable to assume that virtually no women who truly did not have an abortion would claim to have had one". Daling et aP went on further to recalculate the OR inflation reported by Lindefors-Harris et aF9 with all positive reports of induced abortion history (whether by interview or computer) taken as true, and they showed that the spurious risk increase went down from a significant, 50% to a non-significant 16%, attributable to the "under reporting" among controls.
Even closer scrutiny reveals the claim of "under reporting"79 to be on no firmer ground than that of "over reporting". Daling et al3 also offered, as further evidence against the response bias argument, their own finding of a null association of cervical cancer and induced abortion among 214 cases and 321 controls gathered and interviewed in the same manner as those in their breast cancer study. Nevertheless, despite the compelling case made by Daling et aP3 against a response bias interpretation of their own data, Rosenberg, in her accompanying editorial,4 maintained that "the possibility of reporting bias" was "a major concern" in the study, with no acknowledgment whatsoever that Daling et al had indeed addressed the issue.
Outside of the study of Harris et al,58 the only other computer registry based study of induced abortion and breast cancer is that of Howe et al,57 which contains direct evidence against the response bias hypothesis. In interpreting their finding of significantly raised risk (table 2), these authors noted "under reporting" and "inconsistent reporting" on the fetal death certificates. However, they found no evidence of bias, with instances of such misreporting having "occurred similarly among the cases and the controls".57
More recently, Lipworth et al5 suggested that their own study on women in Greece, with its "permissive social environment with respect to induced abortion", might therefore "provide a useful complementary insight" in order to test hypotheses that "have been invoked to explain, in noncausal terms, the reported association between induced abortion and breast cancer". They concluded that their own data (in excellent agreement with those of Daling et a13 and Howe et al57; table 2) did not result from response bias, since "healthy women in Greece report reliably their history of induced abortion" .
Despite the overwhelming evidence that the association of induced abortion and breast cancer does not result from reporting bias, the response bias argument continues to be advanced with vigour. Recently, Rookus and van Leeuwen70 attributed their significantly higher OR obtained from a more rural and traditionally religious region of The Netherlands (compared with a highly urbanised region) to "differential misclassification bias". Surely this is but one of many possible explanations for different results between two regions with substantial differences in many variables, including ethnicity and a host of lifestyle factors. It is also noteworthy that the exposure rates for both regions are very low, and that both show positive overall associations between induced abortion and breast cancer. Also recently, Newcomb et al' have claimed that their results "suggest a bias in reporting", since the RR is slightly higher among American women with induced abortions before versus after legalisation in the US in 1973 (1.35, 95% CI 1.01, 1.80 versus 1.12; 0.84,1.49, respectively). However, their data speak for themselves: Each of these point estimates falls well within the other's CI, thus providing no support for the suggestion of reporting bias. On the contrary, the almost significant (p = 0.09) trend they report for RR to increase with age at diagnosis is continuous, and it shows up even when only post-1973 abortions are included.7'
SPECIFIC EFFECT OF INDUCED ABORTION VERSUS DELAYED CHILDBIRTH
A crucial consideration in the assessment of the real magnitude ofbreast cancer risk attributable specifically to induced abortion is the ability to distinguish this from the known increased risk attributable to a delay in the first full term pregnancy by any means.8' From the point of view of women considering abortion, parous women would be subject only to the independent effect of induced abortion, whereas nulliparous women (about half of American abortion clients), would be subject to both risk enhancing effects of the abortion, depending on their age at time of abortion and if and when they subsequently have any children.
From the point of view of breast cancer aetiology, delay of first full term pregnancy is one of only two risk factors (the other being ionising radiation) known to influence primary carcinogenesis. Presumably, delaying the first complete pregnancy increases the time period during which undifferentiated breast tissue can accumulate potentially tumourigenic mutations. Induced abortion, however, may independently increase risk via the tumour promoting effect of the considerably raised oestradiol concentrations of early pregnancy, while denying a woman the benefit of the differentiating effect of the hormonal milieu of late pregnancy. This differentiating effect is presumably the mechanism by which an early, completed pregnancy confers permanent protection against breast cancer.28 '82 In addition, induced abortion may enhance the oestrogen mediated proliferation of normal but primitive cells, resulting in the presence of more cells which are vulnerable to subsequent primary carcinogenesis.
From the point of view of epidemiology, the differential effects of delaying the first full term pregnancy and artificially terminating a pregnancy in progress have been resolved in two ways. Firstly, by assessing the risk of breast cancer specifically in populations ofnulliparous women, the specific effect of induced abortion can be measured, providing the controls include the nulligravida. In the present metaanalysis, only seven studies assessed risk in nulliparous women. 3 5 53 55 56 6 70 Six of the seven used nulliparous women (all but one3 including the nulligravida) as controls. Only Ewertz and Duffy55 used only parous women as controls, but since they also provided data on the risk of nulliparity per se, we were able to subtract out this effect in order to arrive at the net RR attributable specifically to induced abortion in nulliparous women in their study (table 2) . The resulting pooled OR in the meta-analysis (category 2a, table 3) is the same as that of the overall OR (category 1).
The second method of arriving at the specific overall effect (ie, in parous and nulliparous women; category 1) of induced abortion is to include a term in the calculation of the OR for the effect of age at first live birth or first full term pregnancy. Thirteen of the 21 studies in which an overall OR was reported ( crude ORs, and one65 had insufficient data available on age at first full term pregnancy. Thus there are 15 studies for which the overall effect of induced abortion has been measured with the possible confounding effect of age at full term pregnancy in parous women accounted for. Recalculation of the pooled OR using only these studies slightly reduces the pooled OR (to 1.2), which is still significant (95% CI 1.1,1.3) .
The same is true for other potential confounding variables for which terms were generally included in the multivariate analysesnamely, parity, age at menarche, oral contraceptive use, and some measure of socioeconomic status (usually, educational level). A few studies also adjusted for other factors suspected of influencing breast cancer risk, such as alcohol and fat consumption, although none of these studies reported any significant effects of these variables. (table 2) . However, this can be ascribed to the very large cohort effect in their study. Specifically, since the average patient was over age 40 while the average control was only about 30 when induced abortion was legalised in the US, the potential exposure of patients to induced abortion before first full term pregnancy was undoubtedly much lower than that of control subjects.
Unfortunately, the finding of no differential risk increase for abortion before compared with after the first full term pregnancy in one study3 has been interpreted as conflicting with previous animal data. Specifically, Daling et a3 refer to this finding in their own study as being, "not completely in accord with the results in experimental animals". Rosenberg4 called the same finding "a striking inconsistency with the model". Such conclusions are unwarranted, since the animal model to which these authors referred2 did not include testing the effect of induced abortion after full term pregnancy. Rather, Russo and Russo2 compared breast cancer incidence in rats whose first pregnancy was aborted (via hysterectomy) before exposure to the chemical carcinogen, dimethylbenzanthracene, with that of rats who carried the pregnancy to term and to that of rats who never mated. The aborted group had a high mammary tumour incidence rate (78%), as did the virgin rats (71%) compared with the marked protective effect of carrying the first pregnancy to term (6% tumour incidence). Furthermore, histological examination of breast tissue from these animals revealed incomplete differentiation of primitive structures in the virgin and aborted rats, compared with those allowed to bear pups. While these findings provide excellent experimental evidence of the mechanism responsible for the protective effect ofearly first full term pregnancy (the abrogation of which is one way induced abortion increases breast cancer risk), this animal model system (wherein abortion precedes carcinogen exposure and wherein the effect of abortion on parous animals is not measured) does not fully address the question of the independent effect of induced abortion, which we largely ascribe to the oestradiol mediated promotion of the growth of previously transformed cells.
EFFECT OF INDUCED VERSUS SPONTANEOUS ABORTION
Whatever the details of the mechanism(s) by which induced abortion may independently increase the breast cancer risk, the fact that the first trimester of pregnancy is characterised by high levels of ovarian oestradiol makes this risk factor consistent with most others (eg, early menarche, late menopause, postmenopausal obesity), which are also associated with some form of oestrogen excess. However, the overall lack of association found with spontaneous abortion raises the important question of why any early termination of a pregnancy, whether natural or artificial, does not have the same effect. Various hypotheses have been offered to explain this apparent paradox, ranging from "the inherent difficulty in detecting" spontaneous abortion5 to the possibility that "the relatively short gestational length" of spon-taneously aborted pregnancies might make them less likely to raise breast cancer risk. 3 Lipworth et aP have even suggested that this discrepancy might provide a reason to dismiss the association of induced abortion and breast cancer altogether, as an artifact "generated by subtle information bias".
However, consideration ofthe endocrinology ofnormal compared with threatened early pregnancy provides a straightforward explanation: The first trimester of most pregnancies which end in miscarriage is characterised by subnormal oestradiol secretion. As early as 1976, Kunz and Keller83 found subnormal maternal oestradiol to be the most reliable predictor of first trimester miscarriage. In their 1990 study of 221 pregnancies, Witt et al84 observed that maternal oestradiol in women with apparently normal pregnancies of 11 weeks' gestation or less (from last menstrual period) averaged one third lower in pregnancies that ended in a first trimester miscarriage. More strikingly, they observed that in pregnant women with threatening symptoms (significant vaginal bleeding), oestradiol averaged only one sixth the average normal pregnancy level in pregnancies which went on to miscarry in the first trimester. 84 Recently, Stewart et al85 performed daily longitudinal hormone measurements on 24 normal women of proven fertility. They detected statistically significantly higher maternal oestradiol levels within six days after the luteinizing hormone peak in conceptive cycles (n = 14) that resulted in viable pregnancy. In contrast, conceptive cycles that ended in spontaneous abortion (n= 9) showed a subnormal oestradiol rise that did not significantly exceed non-conceptive levels until the 10th day after the peak, by which time oestradiol begins to decline in a non-pregnant cycle.
EFFECT OF SINGLE VERSUS MULTIPLE INDUCED ABORTIONS
Ten of the studies in the present meta-analysis present overall ORs for two or more induced abortions5 16525456596367-69. However, these 10 studies represent a subset in which the overall OR for one or more induced abortions is lower (1.1; 95% CI: 1.0,1.3) than that obtained for all 21 68 69 The extant data are therefore insufficient to draw any firm conclusions about any overall dose effect of induced abortion at the present time.
A particularly important reason to refrain from dismissing the apparent lack of a dose effect of induced abortion is given in the study of Howe et al,57 whose multiple abortion data set was excluded from the calculations above because it appears to describe only a special case of multiple abortion -ie, two consecutive induced abortions with no live birth intervening. Since this history pertained to 10 cases and no controls (out of 1451 matched pairs), the OR could not be calculated. If the principal mechanism of risk elevation by induced abortion is the oestrogenic growth promotion of existing abnormal cells or clones which would otherwise be eliminated (or at least inhibited) by the completion of the pregnancy, then one would predict a much greater dose effect if two (or more) artificially interrupted pregnancies followed consecutively. Thus, it would be particularly useful if the prospective data base used by Howe et al,57 which has been growing since 1980 (when that study was terminated), were followed up to verify this trend. (1-8 weeks and 9-12 weeks, calculated separately). However, since the overwhelming majority of induced abortions occur in the first trimester, and almost all the rest in the second trimester (which would still be expected to increase risk, as reported by Daling et al'), it is highly unlikely that the overall results reported would be materially affected by third trimester abortions. Indeed, Howe et al7 found that inclusion of third trimester abortions did not affect the results in their study. Of the two studies which divided the analysis according to early and late first trimester abortions, one3 found the later abortions (9-12 weeks) to be associated with a slightly (but insignificantly) higher OR (1.9; 95% CI 1.3,2.9) than the earlier abortions (1-8 weeks: OR= 1.4; 1.0, 1.8), and the other study70 found the reverse (1-8 weeks: OR= 2.1; 1.1,4.2; >8 weeks: OR= 1.6; 0.8,3.5). Thus, there is no reason to suspect that new technologies, (such as mifepristone/misoprostol) that would result in generally earlier terminations, would not also be associated with increased breast cancer risk. EFFECT 3 The former study only considered nulliparous women in this regard, and reported no significant differences in risk, with adjusted ORs ranging from 1.0 to 1.5 over the age range of under 20 years to 30 years and over. Daling et al' also reported no significant differences, but they noted a trend toward increased risk in women with first induced abortion under 18 years old and over 29 years old, which they correlated with the histological data from the human biopsy study of Russo et al. 82 In noting that the rate of cell proliferation is likely to be highest in the youngest subjects, Daling et al' have prudently suggested that the greater elevation in risk for women under 18 at the time of their first (or only) abortion may be real and should be further investigated.
IMPORTANCE OF AGE AT DIAGNOSIS
Because the incidence of breast cancer in the western world rises with age throughout the lifespan86 (whereas in Japan, incidence levels off in the fifth decade and actually drops somewhat later on86), the range of ages at diagnosis in any epidemiological study is the most crucial determinant of the practical significance, in terms of excess cases expected, of the RR determined in the study. Many of the studies published thus far have been restricted to younger women -ie, under age 33, 49 40, 45 ,354596869 or 57,67 generally because only younger women would have been exposed to legalised abortion. As we have already discussed in the present report, most studies that include older women are not only weakened by the lack of exposure of the older women, but also by the cohort effect of having the controls younger than the patients, which tends artificially to lower the calculated ORs. In broad terms, even if the overall weighted pooled OR of 1.3 (±0.1) were to be applicable only to women up to age 50, in whom the incidence of breast cancer is about 2%, and this 30% odds increase were to be applied only to the approximately 800 000 patients having their first induced abortion each year in the US, for example, the calculated excess incidence of breast cancer would be 4700 (± 1600) cases per year in the US. As abortion has been legal in the US for up to a quarter century, an excess incidence of this magnitude should already be occurring. Since over 30 000 cases are already diagnosed in women under age 50 each year, an excess incidence of 4700 might well escape our notice.
Yet, as significant a public health tragedy as this figure suggests, there is reason to believe that it may seriously underestimate the magnitude of the present and future problem. For example, the recent study of Thus, the available evidence so far suggests that the 30% ( ± 10%) increased risk calculated in the present meta-analysis will probably apply, at a minimum, to incidence rates at advanced ages, where such rates are much higher. At a currently estimated lifetime risk in US women of 12%, the 800 000 first abortions performed each year would thus generate 24 500 (± 7800) excess cases each year, once the first cohort exposed to legal abortion reaches their ninth decade, in the fourth decade ofthe 21 st century. Furthermore, it is worthy of emphasis that even this forbidding figure does not reflect the nonspecific effect of induced abortion in delaying first full term pregnancy, which has been discussed in the present review, but was explicitly eliminated from the quantitative meta-analysis. This effect would apply variably to the approximately 800 000 first abortion patients each year, and it could raise the estimate of excess breast cancer incidence which may be attributable to induced abortion considerably.
EFFECTS OF INTERACTION WITH OTHER VARIABLES
A few investigators have begun to explore the possible interaction of induced abortion with at least one risk factor other than age at first full term pregnancy, namely, family history. Thus, Parazzini et al62 found no interaction at all, although their numbers were small, and they also found, contrary to most other reports, no overall effect of reproductive risk factors in women with positive family history, reporting no "strong or significant effect of the best recognized factors for breast cancer risk, and several of the observed trends were in the opposite direction". Only two other studies addressed the interaction of family history and induced abortion. Andrieu et at67 calculated an OR of 7.1 for women with two or more induced abortions and a family history, but the number of subjects (nine patients and four controls) was very low. Daling et aP found only a slightly higher OR for women with a positive first-or second degree family history (1.8 versus 1.5 overall), but they found much stronger associations when they also figured in the effect of age at first (or only) induced abortion. Thus, the OR went up to 3.7 for women whose first induced abortion was over age 30 (14 cases and 3 controls), and it was incalculable for women whose first abortion was under age 18, since such family history and induced abortion history applied to 12 cases and no controls.
Conclusions
We believe that the present review and metaanalysis summarises a literature that documents a remarkably consistent, significant positive association between induced abortion and breast cancer incidence, independent of the effect an induced abortion has in delaying first full term pregnancy. Moreover, the increased risk is seen in both prospective and retrospective studies from around the world, in populations with the widest imaginable differences in ethnicity, diet, socioeconomic and lifestyle factors and social morays, and which also differ widely in size and in many aspects of design, and whose data extend over more than half a century in time. 
